Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +9108048034981 (International callers) or 08048034981 (Indian callers).
Sofocure V is a prescription antiviral medication containing Sofosbuvir (400 mg) and Velpatasvir (100 mg). Manufactured by Emcure Pharmaceuticals, it is used to treat all six main genotypes of chronic Hepatitis C virus (HCV) infection in adults and children aged 3 and older.
Resof L is a combination antiviral medication (Ledipasvir 90 mg + Sofosbuvir 400 used primarily to treat chronic Hepatitis C virus (HCV) infections in adults.
Resof Total (400mg/100mg) is a prescription antiviral medication primarily used to treat chronic Hepatitis C (HCV) infection. It combines Sofosbuvir (400 mg) and Velpatasvir (100 mg) to prevent the virus from replicating.
Dacihep 60 is an antiviral medication containing Daclatasvir (60 mg) used to treat chronic Hepatitis C virus (HCV). It is strictly a prescription drug, usually combined with other medications (like Sofosbuvir)
Ribasure is a brand name for an antiviral medication containing the active ingredient Ribavirin (200 mg per capsule). It is primarily used to treat chronic Hepatitis C virus (HCV) infection in combination with other antiviral medications
Velakast 400/100 is a generic antiviral medication combining Sofosbuvir (400 mg) and Velpatasvir (100 mg). It is widely prescribed to treat chronic Hepatitis C virus (HCV) infections across genotypes 1 through 6 .
MyHep LVIR is a prescription antiviral medication manufactured by Mylan (now Viatris) designed to cure chronic Hepatitis C Virus (HCV) infections in adults and children over the age of three .
MyHep 400 mg (manufactured by Mylan) is a prescription antiviral medication containing Sofosbuvir. It is primarily used in combination regimens (such as with ribavirin, daclatasvir, or velpatasvir) to treat chronic Hepatitis C (HCV) infection by preventing the virus from multiplying.
MYDEKLA 60 is an antiviral prescription medication containing Daclatasvir (60 mg). It is used in combination with other medications (such as Sofosbuvir) to treat chronic Hepatitis C virus (HCV) infections in adults.It works by blocking the viral NS5A protein to stop the virus from replicating
Myhep All 400/100 is a fixed-dose combination antiviral medication containing (400 text{ mg}) of Sofosbuvir and (100 text{ mg}) of Velpatasvir. It is primarily prescribed for the treatment of chronic Hepatitis C virus (HCV) infection in adults and children aged 3 and older.
Myhep Dvir Tablet is a prescription antiviral medication used to treat chronic Hepatitis C virus (HCV) infections. It combines two direct-acting antiviral (DAA) agents—Sofosbuvir (400 mg) and Daclatasvir (60 mg)—to block proteins necessary for the virus to replicate, helping to clear the virus from the blood.
Velpanat is a prescription antiviral medication containing a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg). It is a generic, cost-effective alternative to Epclusa used to manage chronic Hepatitis C virus (HCV) infections across all major genotypes (1 through 6).
Natdac 60 mg (Daclatasvir) is an antiviral prescription medication used in combination therapies (like Sofosbuvir) to treat chronic Hepatitis C virus (HCV) infections in adults. It works as an NS5A inhibitor by preventing the virus from replicating and spreading through the blood.
Hepcinat 400 mg (Sofosbuvir) is an antiviral medication manufactured by Natco Pharma, predominantly used in combination with other antiretroviral drugs for the treatment of chronic Hepatitis C virus (HCV) infection.
Primary Use: Treats chronic HCV (genotypes 1-6). Works by acting as a nucleotide polymerase inhibitor that stops the Hepatitis C virus from multiplying in the body.
Reliferon 3miu Injection is used in the treatment of chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, multiple myeloma, follicular lymphoma, and hairy cell leukemia.
Reliferon 3miu Injection modulates the body's immune system.
Sovihep 400 (Sofosbuvir 400mg) is a direct-acting antiviral medication used to treat chronic Hepatitis C virus (HCV) infection by blocking viral replication. It is primarily manufactured by Zydus Lifesciences and is a prescription-only drug.
Hepcvir L (manufactured by Cipla) is a prescription antiviral medication containing Ledipasvir (90 mg) and Sofosbuvir (400 mg). It is primarily used to treat chronic Hepatitis C virus (HCV) infections.
Hepcvir L is an allopathic, prescription-only medication composed of a fixed-dose combination of Ledipasvir (NS5A inhibitor) and Sofosbuvir (nucleotide analog polymerase inhibitor). Together, these antiviral agents prevent the Hepatitis C virus from multiplying in the body, helping to clear the infection and allowing the liver to recover. The standard adult dosage is typically one tablet daily, taken for 12 weeks as directed by a healthcare professional.
Hepcvel is an antiviral medication combining Sofosbuvir (400 mg) and Velpatasvir (100 mg), primarily used to treat chronic Hepatitis C virus (HCV) infections.
The combination of Sofosbuvir and Velpatasvir works by targeting specific proteins the Hepatitis C virus requires to multiply. By blocking these proteins, the medication stops the virus from replicating and spreading, allowing the virus to be cleared from the blood over the course of treatment (typically 12 weeks).
Hepcdac 60 contains the active pharmaceutical ingredient Daclatasvir (60 mg), a prescription antiviral medication primarily used in combination with Sofosbuvir to treat chronic Hepatitis C virus (HCV) infections. It acts as an NS5A inhibitor to stop the virus from multiplying.